These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15952230

  • 1. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.
    Lam YW, Mobley JA, Evans JE, Carmody JF, Ho SM.
    Proteomics; 2005 Jul; 5(11):2927-38. PubMed ID: 15952230
    [Abstract] [Full Text] [Related]

  • 2. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, Conrad T, Witzigmann H, Weimann A, Schütte C, Hauss J, Büchler M, Thiery J.
    Clin Cancer Res; 2009 Jun 01; 15(11):3812-9. PubMed ID: 19470732
    [Abstract] [Full Text] [Related]

  • 3. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M, Felix K, Hartmann D, Schnölzer M, Nees M, Vorderwülbecke S, Bogumil R, Büchler MW, Friess H.
    Pancreas; 2007 Mar 01; 34(2):205-14. PubMed ID: 17312459
    [Abstract] [Full Text] [Related]

  • 4. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH, Rustgi AK, Blair IA.
    J Proteome Res; 2005 Mar 01; 4(5):1742-51. PubMed ID: 16212428
    [Abstract] [Full Text] [Related]

  • 5. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X, Gong Y, Wang Y, Wu S, Cai Y, He P, Lu Z, Ying W, Zhang Y, Jiao L, He H, Zhang Z, He F, Zhao X, Qian X.
    Proteomics; 2005 Aug 01; 5(13):3423-41. PubMed ID: 16052619
    [Abstract] [Full Text] [Related]

  • 6. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
    Gross M, Top I, Laux I, Katz J, Curran J, Tindell C, Agus D.
    Clin Cancer Res; 2007 Apr 01; 13(7):1979-86. PubMed ID: 17404077
    [Abstract] [Full Text] [Related]

  • 7. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P, Parisi D, Roda G, Casale M, Belluzzi A, Roda E, Mayer L, Roda A.
    Rapid Commun Mass Spectrom; 2007 Apr 01; 21(24):4142-8. PubMed ID: 18022963
    [Abstract] [Full Text] [Related]

  • 8. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC, Oh MJ, Choi SH, Bae CD.
    ANZ J Surg; 2008 Apr 01; 78(4):245-51. PubMed ID: 18366394
    [Abstract] [Full Text] [Related]

  • 9. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.
    Am J Clin Oncol; 2008 Apr 01; 31(2):133-9. PubMed ID: 18391596
    [Abstract] [Full Text] [Related]

  • 10. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX, Zhang B, Yu JK, Liu J, Yang MQ, Zheng S.
    Chin Med J (Engl); 2005 Aug 05; 118(15):1278-84. PubMed ID: 16117882
    [Abstract] [Full Text] [Related]

  • 11. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L, Zhou L, Tao L, Zhang M, Cui JF, Liu YK.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2526-30. PubMed ID: 18067823
    [Abstract] [Full Text] [Related]

  • 12. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK, Tyson DR.
    Urol Oncol; 2006 Sep 25; 24(3):231-6. PubMed ID: 16678055
    [Abstract] [Full Text] [Related]

  • 13. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
    Ricolleau G, Charbonnel C, Lodé L, Loussouarn D, Joalland MP, Bogumil R, Jourdain S, Minvielle S, Campone M, Déporte-Fety R, Campion L, Jézéquel P.
    Proteomics; 2006 Mar 25; 6(6):1963-75. PubMed ID: 16470659
    [Abstract] [Full Text] [Related]

  • 14. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R, Junker H, Zimmermann U, Venz S, Teller S, Giebel J, Scharf C, Woenckhaus C, Dombrowski F, Walther R.
    Cancer Lett; 2008 Aug 08; 266(2):171-85. PubMed ID: 18384941
    [Abstract] [Full Text] [Related]

  • 15. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.
    Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Chen DS, Yu CY, Wen CL, Lu FJ, Chow LP.
    Proteomics; 2006 May 08; 6(9):2865-73. PubMed ID: 16586433
    [Abstract] [Full Text] [Related]

  • 16. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F, Van Coster R, Dhondt G, Devreese B, Van Beeumen J.
    J Proteome Res; 2005 May 08; 4(6):2283-93. PubMed ID: 16335977
    [Abstract] [Full Text] [Related]

  • 17. Strategy combining separation of isotope-labeled unfolded proteins and matrix-assisted laser desorption/ionization mass spectrometry analysis enables quantification of a wide range of serum proteins.
    Liao WL, Turko IV.
    Anal Biochem; 2008 Jun 01; 377(1):55-61. PubMed ID: 18384735
    [Abstract] [Full Text] [Related]

  • 18. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW.
    Clin Cancer Res; 2006 Jan 15; 12(2):432-41. PubMed ID: 16428483
    [Abstract] [Full Text] [Related]

  • 19. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J, Zolotarjova N, Liu H, Nicol G, Boyes BE.
    J Proteome Res; 2005 Jan 15; 4(5):1522-37. PubMed ID: 16212403
    [Abstract] [Full Text] [Related]

  • 20. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS, Zheng YH, Liang WB, Zhang JZ, Yang ZH, Lv ML, Jia J, Zhang L.
    Cancer; 2008 Feb 01; 112(3):544-51. PubMed ID: 18085639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.